«Single dose Ebola vaccine is safe, effective in monkeys
against outbreak strain: VSV - EBOV appears to trigger innate, adaptive immunity.»
Not exact matches
«It was not known whether any of these vaccines could provide protection
against the new
outbreak West African Makona
strain of Ebola Zaire currently circulating in Guinea,» said John Eldridge, Chief Scientific Officer - Vaccines at Profectus Biosciences, Inc. «Our findings show that our candidate vaccines provided complete, single dose protection from a lethal amount of the Makona
strain of Ebola virus.»
National Institutes of Health (NIH) scientists report that a single dose of an experimental Ebola virus (EBOV) vaccine completely protects cynomolgus macaques
against the current EBOV
outbreak strain, EBOV - Makona, when given at least seven days before exposure, and partially protects them if given three days prior.
During the H1N1
outbreak, antiviral drugs offered the only hope
against emergent flu
strains.
It is designed to protect
against Ebola Zaire — the
strain that caused the massive West African
outbreak — and Ebola Sudan, a slightly less frequently seen, but almost as deadly,
strain, and the related Marburg virus.